Advocating for Access to Oral Myeloma Treatments

Published on

Topics include: Treatment and Living Well

Email this program

Get Link

There have been several recent FDA approvals in myeloma-- all of which are oral medications. But what if your doctor suggests a medication for you and your insurance won't cover it? Unfortunately many patients experience this throughout the US...and throughout the world. Meghan Buzby, Director of US Advocacy for the International Myeloma Foundation, discusses the obstacles to accessing myeloma treatment and explain what patients can do to make a difference. 

View more programs featuring

Stay Connected, Sign Up for Alerts!

Be the first to know about new programs and information with email alerts.

Related Programs

Multiple Myeloma and the Black Swan Initiative

What does it take to move myeloma treatments toward a cure? Dr. Bill Bensinger, talks about the Black Swan Initiative, an IMF program, and how it is helping us better understand myeloma.

Published:

The Impact of the Doctor-Patient Relationship On Your Care

The relationship between a doctor and patient is truly critical to care. Patient Una Wilson and Dr. Bensinger help us understand productive and non-productive behaviors when working with your doctor.

Published:

Targeted Myeloma Treatments Bring Hope for Fewer Side Effects and Curative Therapy

Dr. James Berenson discusses the importance of using maintenance therapies with limited side effects and explores targeted treatments that increase the hope for a curative therapy within the next few years.

Published:

Featured Blog
Navigating Cancer Faster

By Andrew Schorr


Page last updated on September 3, 2014